About Dopavision
Dopavision is a company based in Berlin (Germany) founded in 2017.. Dopavision has raised $15.54 million across 3 funding rounds from investors including Novartis, BMBF and Ababax. Dopavision offers products and services including MyopiaX®. Dopavision operates in a competitive market with competitors including Bausch & Lomb, Appasamy Associates, Katalyst Surgical, Lamellar and Moria Surgical, among others.
- Headquarter Berlin, Germany
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.54 M (USD)
in 3 rounds
-
Latest Funding Round
$14.19 M (USD), Series A
Jul 14, 2021
-
Investors
Novartis
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dopavision
Dopavision offers a comprehensive portfolio of products and services, including MyopiaX®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Light-based therapy to slow myopia progression in children via apps.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Dopavision
Dopavision has successfully raised a total of $15.54M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $14.19 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $14.2M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series A - Dopavision | Valuation | Seventure Partners | |
| Jun, 2019 | Amount | Seed - Dopavision | Valuation | Boehringer Ingelheim Venture Fund | |
| Jun, 2018 | Amount | Grant - Dopavision | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dopavision
Dopavision has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Novartis, BMBF and Ababax. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Founded Year | Domain | Location | |
|
Healthcare investments are targeted by Boehringer Ingelheim Venture Fund.
|
Founded Year | Domain | Location | |
|
Flying Health is recognized as a leading ecosystem for digital and sustainable healthcare solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dopavision
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Dopavision
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dopavision Comparisons
Competitors of Dopavision
Dopavision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bausch & Lomb, Appasamy Associates, Katalyst Surgical, Lamellar and Moria Surgical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ophthalmic pharmaceuticals and instruments are developed for eye care.
|
|
| domain | founded_year | HQ Location |
Ophthalmic instruments and pharmaceutical products are developed for eye care.
|
|
| domain | founded_year | HQ Location |
Titanium ophthalmic surgical instruments are manufactured and repaired.
|
|
| domain | founded_year | HQ Location |
Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies
|
|
| domain | founded_year | HQ Location |
Precision instruments for eye surgery are designed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dopavision
Frequently Asked Questions about Dopavision
When was Dopavision founded?
Dopavision was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Dopavision located?
Dopavision is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Is Dopavision a funded company?
Dopavision is a funded company, having raised a total of $15.54M across 3 funding rounds to date.
What does Dopavision do?
Dopavision was founded in 2017 in Berlin, Germany, within the health technology sector. Digital therapeutics for myopia are created by the company, focusing on light stimulation delivered to photosensitive retinal cells. Dopamine modulation is facilitated to regulate eye growth. A mobile application named Myopiax is provided for children, integrating treatment with engaging activities. Operations center on addressing pediatric vision issues through non-invasive methods.
Who are the top competitors of Dopavision?
Dopavision's top competitors include Bausch & Lomb, Appasamy Associates and Katalyst Surgical.
What products or services does Dopavision offer?
Dopavision offers MyopiaX®.
Who are Dopavision's investors?
Dopavision has 7 investors. Key investors include Novartis, BMBF, Ababax, Seventure Partners, and Boehringer Ingelheim Venture Fund.